NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Vaccine Efficacy


Return to Library

Free Vaccine Efficacy Articles


Research results from J. Sun and colleagues update understanding of DNA vaccines



2009 JUN 29 - (NewsRx.com) -- "In higher eukaryotes, introns are usually required for efficient pre-mRNA processing. However, some viruses have alternative approaches involving posttranscriptional regulatory elements (PREs) to enhance intronless heterologous gene expression through enabling stability and 30 end formation, and to facilitate the nucleocytoplasmic export of unspliced mRNAs," researchers in Beijing, People's Republic of China report.

"In the current study, we compared the human cytomegalovirus (hCMV) immediate/early (IE) intronA, as well as virus-derived PREs-the PRE of Hepatitis B virus (HPRE) and Woodchuck Hepatitis virus (WPRE) on their ability to enhance antigen gene expression in vitro and immune responses induced by DNA vaccination in animal. Among all the constructs, the plasmids carrying the HPRE element showed the highest gene expression level in both in vivo and in vitro models. During immunization of mice with low doses (10 mg) of HIV-1 DNA vaccine, only -intronA/+HPRE and +intronA/+HPRE vaccine constructs induced anti-Gag antibodies, although the +intronA/+WPRE construct also elicited antigen-specific cellular immune responses. In addition, pInHGag (+intronA/+HPRE) at a 10 mg dose could induce higher anti-Gag antibody level than that induced by pGag (+intronA/+HPRE) or pInGag (+intronA/+HPRE) at 40 mg dose (p < 0.05)," wrote J. Sun and colleagues.

The researchers concluded: "Our data are useful for the optimization of heterologous expression and immunogenicity of DNA vaccines."

Sun and colleagues published their study in DNA and Cell Biology (Posttranscriptional Regulatory Elements Enhance Antigen Expression and DNA Vaccine Efficacy. DNA and Cell Biology, 2009;28(5):233-240).

For additional information, contact Y. Liu, Chinese Center Diseases Control & Prevention, State Key Laboratory Infectious Disease Prevention & Control, National Center AIDS STD Control & Prevention, 27 Nanwei Rd., Beijing 100050, People's Republic of China.

Publisher contact information for the journal DNA and Cell Biology is: Mary Ann Liebert Inc., 140 Huguenot Street, 3RD FL, New Rochelle, NY 10801, USA.

Keywords: People's Republic of China, Beijing, AIDS, Acquired Immunodeficiency Syndrome, Biotechnology, Cell Biology, Cytomegalovirus, DNA Research, DNA Vaccines, Gastroenterology, HBV, HIV, Hepatitis B Virus, Hepatology, Human Immunodeficiency Virus Viral Infection, Immunization, Infectious Disease, Medical Device, Vaccination, Vaccine Efficacy, Virology.

This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login